MiRecas

Industry: Covid-19 Testing

To address the need for fast and accurate tests for RNA viruses such as Covid-19, MiRecas out of Georgia State University is developing an electrochemical sensor that can identify disease biomarkers to diagnose illness with an accuracy comparable to PCR lab tests.

The turn-around time for the MiRecas test is much faster than a PCR, taking only tens of minutes to provide results. Further, the cost of the test’s reagents is estimated to be half of that for reagents of traditional tests.

Back to companies